Cyclophosphamide Therapy for Refractory Antibody-Mediated Rejection (AMR) in Kidney Transplants
Clinical trial NCT01630538 · TERMINATED
Trial details
- NCT number
- NCT01630538
- Sponsor
- University of Manitoba
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-01
- Primary completion
- 2018-01-18
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.